Spotlight Asset Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$20M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$8.26M |
| 3 |
AGF US Market Neutral Anti-Beta Fund
BTAL
|
+$6.44M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.02M |
| 5 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$11.4M |
| 2 |
iShares Preferred and Income Securities ETF
PFF
|
+$4.57M |
| 3 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$4.47M |
| 4 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$4.11M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.66% |
| 2 | Consumer Discretionary | 6.01% |
| 3 | Communication Services | 5.27% |
| 4 | Healthcare | 4.16% |
| 5 | Financials | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Sarepta Therapeutics
SRPT
$1.73B
| – | – |
-10,000
| Closed | -$112K |
|
|
152
Sarepta Therapeutics
SRPT
$1.73B
| – | – |
-5,700
| Closed | -$558K |
|
153
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
| – | – |
-3,199
| Closed | -$369K |
|
|
154
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.4B
| – | – |
-46,924
| Closed | -$4.09M |
|
155
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
| – | – |
-2,020
| Closed | -$239K |
|
156
Wells Fargo
WFC
$266B
| – | – |
-7,854
| Closed | -$225K |
|
|
157
Invesco S&P MidCap Momentum ETF
XMMO
$7.45B
| – | – |
-83,643
| Closed | -$4.11M |
|
Similar funds
Spotlight Asset Group's Q2 2020 Portfolio in Review
As of Q2 2020, Spotlight Asset Group held 157 positions worth $239M, up 27% from $188M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Spotlight Asset Group deployed $19.1M of net new capital in Q2 2020, opening 41 new positions and adding to 34 existing holdings. Its largest new stake was AGF US Market Neutral Anti-Beta Fund: 260,984 shares worth $6.35M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 6.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $11.4M trimmed.
- Spotlight Asset Group's largest Q2 2020 buy was AGF US Market Neutral Anti-Beta Fund: 260,984 shares worth $6.35M.
- Spotlight Asset Group added most to iShares Core US Aggregate Bond ETF in Q2 2020, an estimated $20M increase.
- Spotlight Asset Group's biggest Q2 2020 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $11.4M.
- Spotlight Asset Group fully exited iShares Preferred and Income Securities ETF in Q2 2020, selling an estimated $4.57M.
- Spotlight Asset Group's ten largest holdings make up 56% of its $239M portfolio in Q2 2020.
- Spotlight Asset Group opened 41 new positions and closed 17 in Q2 2020.
- Spotlight Asset Group's portfolio value rose 27% quarter-over-quarter to $239M.
Based on Spotlight Asset Group's 13F filing for Q2 2020, filed 23 Jul 2020.